Press Releases

Email Alerts

Feb 12, 2018

Biostage Appoints to its Scientific Advisory Board Charles S. Cox, Jr., MD

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat conditions of the esophagus, bronchus and trachea, today announced the appointment of Charles...
- Photos 1
Feb 7, 2018

Biostage, Inc. Names Jason Chen Chairman of its Board of Directors

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced that it...
- Photos 1
Feb 6, 2018

Biostage to Host Conference Call to Provide Business Update

- Conference Call with Live Audio Webcast on Tuesday, February 13th at 9:00 AM ET -

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced that on...
Jan 31, 2018

Biostage Appoints to its Scientific Advisory Board Christine Finck, MD, Executive Vice President, Surgeon-in-Chief at Connecticut Children's Medical Center

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced the...
Jan 3, 2018

Biostage Closes $4.2 Million Private Placement

- Investors strongly back technology, advancement to the clinic in U.S. Market-

Biostage, Inc. (OTCQB: BSTG/BSTGD), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...

Show per page